Download PDF
Semin Musculoskelet Radiol 2001; 05(2): 177-182
DOI: 10.1055/s-2001-15677
Nuclear Imaging of Bone Tumors

Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Nuclear Imaging of Bone Tumors: Thallium-201 Scintigraphy

Hisashi Sumiya, Junichi Taki, Takahiro Higuchi, Norihisa Tonami
  • Department of Nuclear Medicine, Kanazawa University School of Medicine, Kanazawa, Japan
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

ABSTRACT

201Tl scintigraphy provides important information for the management of patients with bone tumors. Although the role for staging the disease of bone tumors and for differentiation of benign from malignant lesions is limited, 201Tl scintigraphy reflects the disease activity after treatment and it should be used to determine the treatment response and for early diagnosis of recurrence. Baseline study is essential for future reference to evaluate the response to preoperative chemotherapy and to detect recurrence after surgery. Sequential 201Tl scintigraphy before and after treatment is useful in assessing the grade of response of the tumor to chemotherapy. The early prediction of chemotherapeutic effect by 201Tl scintigraphy during treatment will affect the management of patients who do not respond to the therapy. This is of special importance to determine whether the patient needs an amputation or a limb-salvage surgery.

KEYWORD

Thallium - bone tumor - chemotherapy

REFERENCES

  • 1 Tsuchiya H, Tomita K, Minematsu K. Limb salvage using distraction osteogenesis. A classification of the technique.  J Bone Joint Surg Br . 1997;  79 403-411
    CrossrefPubMedGoogle Scholar
  • 2 Jaffe N, Knapp J, Chuang V P. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies.  Cancer . 1983;  51 402-407
    PubMedGoogle Scholar
  • 3 Eilber F R, Morton D L, Eckardt J, Grant T, Weisenburger T. Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy.  Cancer . 1984;  53 2579-2584
    PubMedGoogle Scholar
  • 4 Tonami N, Hisada K. Clinical experience of tumor imaging with thallium-201chloride.  Clin Nucl Med . 1977;  2 75-81
    PubMedGoogle Scholar
  • 5 Sumiya H, Taki J, Tsuchiya H. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.  J Nucl Med . 1998;  39 1600-1604
    PubMedGoogle Scholar
  • 6 Elgazzar A H, Malki A A, Abdel Dayem M H. Role of thallium-201 in the diagnosis of solitary bone lesions.  Nucl Med Commun . 1989;  10 477-485
    PubMedGoogle Scholar
  • 7 Matsui R, Komori T, Nakata Y. Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue.  Kaku Igaku . 1999;  36 219-228
    PubMedGoogle Scholar
  • 8 Caluser C, Healey J, Macapinlac H. Tl-201 uptake in recurrent pigmented villonodular synovitis. Correlation with three-phase bone imaging.  Clin Nucl Med . 1992;  17 751-753
    PubMedGoogle Scholar
  • 9 Taki J, Sumiya H, Tsuchiya H. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.  J Nucl Med . 1997;  38 501-506
    PubMedGoogle Scholar
  • 10 Caluser C I, Abdel Dayem M H, Macapinlac H A. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.  Eur J Nucl Med . 1994;  21 1198-1205
    PubMedGoogle Scholar
  • 11 Hori A, Sumiya H, Taki J. Thallium-201 SPECT in differentiating bone infarction from metastatic lesions in osteosarcoma.  Clin Nucl Med . 1997;  22 752-755
    CrossrefPubMedGoogle Scholar
  • 12 Koyama M. Clinical usefulness of 201Tl-chloride scintigraphy for the diagnosis of bone metastases.  Kaku Igaku . 1995;  32 918
    PubMedGoogle Scholar
  • 13 Sumiya H, Taki J, Tonami N, Tsuchiya H, Nonomura A. Thallium-201 scintigraphy in prediction of chemotherapeutic response in bone and soft tissue tumors. Comparison between early and delayed scintigraphy.  J Nucl Med . 1999;  40 132P-133P
    PubMedGoogle Scholar
  • 14 Blocklet D, Seret A, Popa N, Schoutens A. Maximum-likelihood reconstruction with ordered subsets in bone SPECT.  J Nucl Med . 1999;  40 1978-1984
    PubMedGoogle Scholar
  • 15 Tsubuku M. Clinical significance of whole body thallium-201 chloride scintigraphy in multiple myeloma.  Kaku Igaku . 1996;  33 33-47
    PubMedGoogle Scholar
  • 16 Thrall J H, Ziessman H A. Nuclear Medicine: The Requisites.  St. Louis: Mosby 1995: 93-128
    Google Scholar
  • 17 Etchebehere E C, Etchebehere M, Gamba R, Belangero W, Camargo E E. Orthopedic pathology of the lower extremities: scintigraphic evaluation in the thigh, knee, and leg.  Semin Nucl Med . 1998;  28 41-61
    PubMedGoogle Scholar
  • 18 Menendez L R, Fideler B M, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.  J Bone Joint Surg Am . 1993;  75 526-531
    PubMedGoogle Scholar
  • 19 Scott A M, Larson S M. Tumor imaging and therapy.  Radiol Clin North Am . 1993;  31 859-879
    PubMedGoogle Scholar
  • 20 Rosen G, Loren G J, Brien E W. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.  Clin Orthop . 1993;  293 302-306
    PubMedGoogle Scholar
  • 21 Lin J, Leung W T, Ho S K. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.  Eur J Nucl Med . 1995;  22 553-555
    PubMedGoogle Scholar
  • 22 Ohtomo K, Terui S, Yokoyama R. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.  J Nucl Med . 1996;  37 1444-1448
    PubMedGoogle Scholar
  • 23 Vande Streek P, Carretta R F, Weiland F L, Shelton D K. Upper extremity radionuclide bone imaging: the wrist and hand.  Semin Nucl Med . 1998;  28 14-24
    CrossrefPubMedGoogle Scholar
  • 24 Kunisada T, Ozaki T, Kawai A. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.  Cancer . 1999;  86 949-956
    CrossrefPubMedGoogle Scholar
  • 25 van der Woude J H, Bloem J L, Verstraete K L. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.  AJR . 1995;  165 593-598
    PubMedGoogle Scholar
  • 26 Kostakoglu L, Panicek D M, Divgi C R. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.  Eur J Nucl Med . 1995;  22 1232-1237
    PubMedGoogle Scholar
  • 27 Ramanna L, Waxman A, Binney G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.  J Nucl Med . 1990;  31 567-572
    PubMedGoogle Scholar
  • 28 Tsuda T, Kubota M, Yoshida S. 201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors.  Kaku Igaku . 1994;  31 1477-1494
    PubMedGoogle Scholar
      >